Hospira Misled Investors To Pump Up Stock Prices: Suit

Law360, New York (December 9, 2011, 9:05 PM EST) -- A pension plan lodged a putative class action Thursday in Illinois federal court accusing cancer drug maker Hospira Inc. and three executives of artificially inflating stock prices in part by withholding information about a regulatory probe into drug production and other activities.

IUE-CWA Local 475 Pension Plan alleges the specialty medication company sugarcoated two U.S. Food and Drug Administration investigations of its production of cancer drugs and infusion pumps and made misleading statements about the company's overall financial health.

These practices artificially bolstered the prices of...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

IUE-CWA Local 475 Pension Plan v. Hospira, Inc. et al


Case Number

1:11-cv-08746

Court

Illinois Northern

Nature of Suit

850(Securities/Commodities)

Judge

Honorable Amy J. St. Eve

Date Filed

December 9, 2011

Companies

Government Agencies

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.